{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:03:17Z","timestamp":1781708597425,"version":"3.54.5"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.ccm.2013.01.009","type":"journal-article","created":{"date-parts":[[2013,4,9]],"date-time":"2013-04-09T03:47:49Z","timestamp":1365479269000},"page":"283-292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Human Immunodeficiency Virus\u2013Associated Pulmonary Arterial Hypertension"],"prefix":"10.1016","volume":"34","author":[{"given":"Christopher F.","family":"Barnett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla Y.","family":"Hsue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccm.2013.01.009_bib1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-med-042909-093756","article-title":"HIV infection, inflammation, immunosenescence, and aging","volume":"62","author":"Deeks","year":"2011","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.ccm.2013.01.009_bib2","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/01.aids.0000327512.76126.6e","article-title":"Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors","volume":"22","author":"Boccara","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.ccm.2013.01.009_bib3","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.jacc.2012.02.024","article-title":"Sudden cardiac death in patients with human immunodeficiency virus infection","volume":"59","author":"Tseng","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccm.2013.01.009_bib4","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1097\/QAD.0b013e32832e7140","article-title":"Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients","volume":"23","author":"Hsue","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.ccm.2013.01.009_bib5","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jama.299.3.324","article-title":"Pulmonary hypertension","volume":"299","author":"Barnett","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.ccm.2013.01.009_bib6","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/j.jacc.2004.02.037","article-title":"Clinical classification of pulmonary hypertension","volume":"43","author":"Simonneau","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccm.2013.01.009_bib7","series-title":"Global report: UNAIDS report on the global AIDS epidemic 2012","author":"WHO\/UNAIDS","year":"2012"},{"key":"10.1016\/j.ccm.2013.01.009_bib8","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1086\/383037","article-title":"Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy","volume":"38","author":"Zuber","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2013.01.009_bib9","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0046-8177(87)80417-3","article-title":"Membranoproliferative glomerulonephritis and plexogenic pulmonary arteriopathy in a homosexual man with acquired immunodeficiency syndrome","volume":"18","author":"Kim","year":"1987","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ccm.2013.01.009_bib10","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1378\/chest.100.5.1268","article-title":"Primary pulmonary hypertension in HIV infection","volume":"100","author":"Speich","year":"1991","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2013.01.009_bib11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1164\/rccm.200704-541OC","article-title":"Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era","volume":"177","author":"Sitbon","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2013.01.009_bib12","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/QAD.0b013e3282f7cd42","article-title":"Role of HIV and human herpesvirus-8 infection in pulmonary arterial hypertension","volume":"22","author":"Hsue","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.ccm.2013.01.009_bib13","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/cid\/ciq066","article-title":"High prevalence of echocardiographic abnormalities among HIV-infected persons in the era of highly active antiretroviral therapy","volume":"52","author":"Mondy","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2013.01.009_bib14","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/QAD.0b013e328354f5a1","article-title":"Prevalence and risk factors associated with pulmonary hypertension in HIV-infected patients on regular follow-up","volume":"26","author":"Quezada","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.ccm.2013.01.009_bib15","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1378\/chest.118.4.1133","article-title":"HIV-Related pulmonary hypertension: analytic review of 131 cases","volume":"118","author":"Mehta","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2013.01.009_bib16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/CIRCHEARTFAILURE.109.854943","article-title":"Impact of HIV infection on diastolic function and left ventricular mass","volume":"3","author":"Hsue","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ccm.2013.01.009_bib17","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.bbrc.2005.05.198","article-title":"Induction of apoptosis and endothelin-1 secretion in primary human lung endothelial cells by HIV-1 gp120 proteins","volume":"333","author":"Kanmogne","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ccm.2013.01.009_bib18","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1183\/09031936.98.11030554","article-title":"Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients","volume":"11","author":"Humbert","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2013.01.009_bib19","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1164\/ajrccm\/145.5.1196","article-title":"Primary pulmonary hypertension in association with human immunodeficiency virus infection. A possible viral etiology for some forms of hypertensive pulmonary arteriopathy","volume":"145","author":"Mette","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ccm.2013.01.009_bib20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1164\/rccm.200601-005OC","article-title":"HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIV-nef-infected macaques","volume":"174","author":"Marecki","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2013.01.009_bib21","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1165\/rcmb.2011-0434OC","article-title":"Physiologic changes in a non-human primate model of HIV-associated pulmonary arterial hypertension","volume":"48","author":"George","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.ccm.2013.01.009_bib22","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1089\/aid.2011.0021","article-title":"Human immunodeficiency virus nef signature sequences are associated with pulmonary hypertension","volume":"28","author":"Almodovar","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.ccm.2013.01.009_bib23","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1189\/jlb.0405194","article-title":"HIV-1 TAT represses transcription of the bone morphogenic protein receptor-2 in U937 monocytic cells","volume":"79","author":"Caldwell","year":"2006","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.ccm.2013.01.009_bib24","doi-asserted-by":"crossref","first-page":"654","DOI":"10.7326\/0003-4819-124-7-199604010-00006","article-title":"Immunopathogenic mechanisms of HIV infection","volume":"124","author":"Fauci","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccm.2013.01.009_bib25","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1164\/ajrccm.153.4.8616557","article-title":"Primary pulmonary hypertension in HIV infection: an outcome determined by particular HLA class II alleles","volume":"153","author":"Morse","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 3","key":"10.1016\/j.ccm.2013.01.009_bib26","doi-asserted-by":"crossref","first-page":"S375","DOI":"10.1093\/infdis\/jis200","article-title":"Immunologic basis of cardiovascular disease in HIV-infected adults","volume":"205","author":"Hsue","year":"2012","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ccm.2013.01.009_bib27","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/QAD.0b013e32835099ae","article-title":"Cardiopulmonary function in individuals with HIV infection in the antiretroviral therapy era","volume":"26","author":"Morris","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.ccm.2013.01.009_bib28","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1182\/blood.V93.12.4232","article-title":"Infection with human immunodeficiency virus-1 increases expression of vascular endothelial cell growth factor in T cells: implications for acquired immunodeficiency syndrome-associated vasculopathy","volume":"93","author":"Ascherl","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.ccm.2013.01.009_bib29","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa035115","article-title":"Expression of human herpesvirus 8 in primary pulmonary hypertension","volume":"349","author":"Cool","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2013.01.009_bib30","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1126\/science.7997879","article-title":"Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma","volume":"266","author":"Chang","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.ccm.2013.01.009_bib31","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1056\/NEJM199804023381403","article-title":"Sexual transmission and the natural history of human herpesvirus 8 infection","volume":"338","author":"Martin","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2013.01.009_bib32","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1097\/01.aids.0000176230.94226.06","article-title":"Human herpes virus 8 in HIV and non-HIV infected patients with pulmonary arterial hypertension in France","volume":"19","author":"Montani","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.ccm.2013.01.009_bib33","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.3201\/eid1109.040880","article-title":"Human herpesvirus 8 and pulmonary hypertension","volume":"11","author":"Nicastri","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ccm.2013.01.009_bib34","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1164\/rccm.201204-0609ED","article-title":"Injection drug use as a \u201csecond hit\u201d in the pathogenesis of HIV-associated pulmonary hypertension","volume":"185","author":"George","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2013.01.009_bib35","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1164\/rccm.201110-1909OC","article-title":"Enhanced pulmonary arteriopathy in simian immunodeficiency virus-infected macaques exposed to morphine","volume":"185","author":"Spikes","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2013.01.009_bib36","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1164\/ajrccm.155.3.9117037","article-title":"HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study","volume":"155","author":"Opravil","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2013.01.009_bib37","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1161\/01.CIR.89.6.2722","article-title":"Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension","volume":"89","author":"Petitpretz","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ccm.2013.01.009_bib38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/QAD.0b013e328331c65e","article-title":"HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era","volume":"24","author":"Degano","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.ccm.2013.01.009_bib39","doi-asserted-by":"crossref","first-page":"14S","DOI":"10.1378\/chest.126.1_suppl.14S","article-title":"Screening, early detection, and diagnosis of pulmonary arterial hypertension. ACCP evidence-based clinical practice guidelines","volume":"126","author":"McGoon","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2013.01.009_bib40","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1097\/QAD.0b013e3283579653","article-title":"Doppler echocardiography does not accurately estimate pulmonary artery systolic pressure in HIV-infected patients","volume":"26","author":"Selby","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.ccm.2013.01.009_bib41","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0735-1097(02)01744-8","article-title":"Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension","volume":"39","author":"Raymond","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccm.2013.01.009_bib42","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/CIRCULATIONAHA.106.674028","article-title":"Comprehensive invasive and noninvasive approach to the right ventricle\u2013pulmonary circulation unit: state of the art and clinical and research implications","volume":"120","author":"Champion","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ccm.2013.01.009_bib43","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1164\/ajrccm.162.5.2004042","article-title":"Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension","volume":"162","author":"Aguilar","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2013.01.009_bib44","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2009.01.004","volume":"53","author":"McLaughlin","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccm.2013.01.009_bib45","first-page":"282","article-title":"Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement","volume":"40","author":"Pugliese","year":"2000","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.ccm.2013.01.009_bib46","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1161\/CIRCULATIONAHA.110.973750","article-title":"Effects of HIV protease inhibitors on progression of monocrotaline- and hypoxia-induced pulmonary hypertension in rats","volume":"122","author":"Gary-Bobo","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ccm.2013.01.009_bib47","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. Available at: http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/AdultandAdolescentGL.pdf."},{"key":"10.1016\/j.ccm.2013.01.009_bib48","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/jama.2012.7961","article-title":"Antiretroviral treatment of adult HIV infection: 2012 recommendations of the international antiviral society\u2014USA panel","volume":"308","author":"Thompson","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ccm.2013.01.009_bib49","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1161\/CIRCULATIONAHA.104.488486","article-title":"Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension","volume":"111","author":"Sitbon","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ccm.2013.01.009_bib50","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"30","author":"Gali\u00e8","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccm.2013.01.009_bib51","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(08)60919-8","article-title":"Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study):\u00a0a double-blind, randomised controlled trial","volume":"371","author":"Gali\u00e8","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2013.01.009_bib52","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2147\/vhrm.2006.2.4.411","article-title":"Sildenafil in the treatment of pulmonary hypertension","volume":"2","author":"Barnett","year":"2006","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.ccm.2013.01.009_bib53","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/CIRCULATIONAHA.108.839274","article-title":"Tadalafil therapy for pulmonary arterial hypertension","volume":"119","author":"Gali\u00e8","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ccm.2013.01.009_bib54","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/01.cpm.0000218606.74161.d4","article-title":"Noninfectious pulmonary complications of HIV","volume":"13","author":"Ieong","year":"2006","journal-title":"Clin Pulm Med"},{"key":"10.1016\/j.ccm.2013.01.009_bib55","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1097\/00002030-200109070-00026","article-title":"Sildenafil in HIV-related pulmonary hypertension","volume":"15","author":"Schumacher","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.ccm.2013.01.009_bib56","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00002030-199910220-00001","article-title":"Interaction of sildenafil and indinavir when co-administered to HIV-positive patients","volume":"13","author":"Merry","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.ccm.2013.01.009_bib57","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2125.2000.00245.x","article-title":"Pharmacokinetic interactions between sildenafil and saquinavir\/ritonavir","volume":"50","author":"Muirhead","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ccm.2013.01.009_bib58","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2174\/157016212799937263","article-title":"Sildenafil plasma concentrations in two HIV patients with pulmonary hypertension treated with ritonavir-boosted protease inhibitors","volume":"10","author":"Chinello","year":"2012","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.ccm.2013.01.009_bib59","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1164\/rccm.200404-445OC","article-title":"Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension","volume":"170","author":"Sitbon","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2013.01.009_bib60","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1183\/09031936.00094808","article-title":"Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension","volume":"33","author":"Degano","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2013.01.009_bib61","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1161\/CIRCULATIONAHA.107.742510","article-title":"Ambrisentan for the treatment of pulmonary arterial hypertension: results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2","volume":"117","author":"Gali\u00e8","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ccm.2013.01.009_bib62","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1177\/0091270011423662","article-title":"Clinical pharmacokinetics and drug-drug interactions of endothelin receptor antagonists in pulmonary arterial hypertension","volume":"52","author":"Venitz","year":"2012","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.ccm.2013.01.009_bib63","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jacc.2012.03.025","article-title":"Long-term hepatic safety of ambrisentan in patients with pulmonary arterial hypertension","volume":"60","author":"Ben-Yehuda","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccm.2013.01.009_bib64","first-page":"A5913","article-title":"PAH therapy in HIV: lack drug-drug interaction between ambrisentan and ritonavir","volume":"183","author":"Gillies","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2013.01.009_bib65","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0300-8932(03)76889-4","volume":"56","author":"Cea-Calvo","year":"2003","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.ccm.2013.01.009_bib66","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1183\/09031936.03.00057703","article-title":"Inhaled iloprost is a potent acute pulmonary vasodilator in HIV-related severe pulmonary hypertension","volume":"23","author":"Ghofrani","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2013.01.009_bib67","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2010.01.027","article-title":"Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial","volume":"55","author":"McLaughlin","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccm.2013.01.009_bib68","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1183\/09059180.00009011","article-title":"How to detect disease progression in pulmonary arterial hypertension","volume":"21","author":"Vachi\u00e9ry","year":"2012","journal-title":"Eur Respir Rev"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523113000282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523113000282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:48:12Z","timestamp":1759452492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523113000282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0272523113000282"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2013.01.009","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human Immunodeficiency Virus\u2013Associated Pulmonary Arterial Hypertension","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2013.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}